New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges

@inproceedings{Vecchiarelli2012NewAI,
  title={New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges},
  author={Anna Vecchiarelli and Eva Pericolini and Elena Gabrielli and Donatella Pietrella},
  booktitle={Front. Microbio.},
  year={2012}
}
The commensal fungus Candida albicans causes mucosal candidiasis in the rapidly expanding number of immunocompromised patients. Mucosal candidiasis includes oropharyngeal, esophageal, gastrointestinal, and vaginal infections. Vulvovaginal candidiasis (VVC) and antimycotic-refractory recurrent VVC is a frequent problem in healthy childbearing women. Both these mucosal infections can affect the quality of life and finding new therapeutical and preventive approaches is a challenge. A vaccine… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

Fungal vaccines and immunotherapeutics.

  • Cold Spring Harbor perspectives in medicine
  • 2014
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 101 REFERENCES

Dendritic cells at the oral mucosal interface.

  • Journal of dental research
  • 2006
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Mucosal Immunity and Candida albicans Infection

  • Clinical & developmental immunology
  • 2011
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Defining criteria for anti-mannan antibodies to protect against candidiasis.

  • Current molecular medicine
  • 2005
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…